HPDE was expected to show the “pure” phenotype of mutated GNAS, whereas the pancreatic cancer cells were expected to manifest the phenotype of mutated GNAS plus mutated KRAS (the latter corresponds to common mutations found in IPMN) [3], [4]. Here, GNAS is linked to familial pancreatic carcinoma.